[Is there a place for arterial chemoembolization of the liver in the treatment for hepatocellular carcinoma?].
Trinchet
J C
JC
Service d'Hépato-Gastroentérologie, Hôpital Jean-Verdier.
Mathieu
D
D
Beaugrand
M
M
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D004359:Drug Therapy, Combination; D004621:Embolization, Therapeutic / Q000009:adverse effects / Q000379:methods*; D006801:Humans; D007459:Iodized Oil / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008099:Liver / Q000473:pathology; D008103:Liver Cirrhosis / Q000150:complications; D008113:Liver Neoplasms / Q000209:etiology / Q000401:mortality / Q000628:therapy*; D009336:Necrosis
D000970:Antineoplastic Agents; D007459:Iodized Oil
Reste-t-il une place pour la chimioembolisation artérielle hépatique dans le traitement du carcinome hépatocellulaire?